Skip to main
AHCO
AHCO logo

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth Corp is expected to realize an annual topline growth of 12-15% through ongoing investments in technology and strategic mergers and acquisitions within its fragmented industry. The recent acquisition of AeroCare strengthens the company's national footprint and enhances its value proposition with payors, while also advancing its connected health strategy. Additionally, the company's scalable platform and low-cost infrastructure are anticipated to foster strong operating leverage and margin expansion as it continues to capitalize on cross-selling opportunities and expand its product offerings.

Bears say

AdaptHealth Corp has reported a decline in key revenue segments, with diabetes revenue dropping by 8.0% year-over-year and sleep revenue falling by 3.0%, indicating challenges in two crucial areas of its business. The company has also revised its 2025 revenue and adjusted EBITDA guidance downwards by $40 million and $5 million, respectively, reflecting concerns about market share and asset sales. Furthermore, the potential for unforeseen acquisition integration difficulties and the failure to achieve operating leverage could negatively impact adjusted EBITDA, contributing to a negative outlook on the stock.

AdaptHealth Corp (AHCO) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 5 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.